In reply: Bereznicki and colleagues have reinforced the importance of patient education in optimising warfarin safety, while highlighting the need for role clarification in its provision.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- 1 NHMRC Centre of Research Excellence in Patient Safety, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC.
- 2 Melbourne Pathology, Melbourne, VIC.
- 3 Haemostasis and Thrombosis Unit, Alfred Health, Melbourne, VIC.
- 4 Monash University, Melbourne, VIC.
Correspondence: Judy.Lowthian@med.monash.edu.au
- 1. Garcia DA, Witt DM, Hylek E, et al. Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum. Ann Pharmacother 2008; 42: 979-988.
- 2. Fang MC, Machtinger EL, Wang F, Schillinger D. Health literacy and anticoagulation-related outcomes among patients taking warfarin. J Gen Intern Med 2006; 21: 841-846.
- 3. Hutchison LC, Jones SK, West DS, Wei JY. Assessment of medication management by community-living elderly persons with two standardized assessment tools: a cross-sectional study. Am J Geriatr Pharmacother 2006; 4: 144-153.
- 4. Kimmel SE, Chen Z, Price M, et al. The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Arch Intern Med 2007; 167: 229-235.
- 5. Newall F, Monagle P, Johnston L. Patient understanding of warfarin therapy: a review of education strategies. Hematology 2005; 10: 437-442.
Online responses are no longer available. Please refer to our instructions for authors page for more information.